Categories Other Industries

Xcel Energy rolls out most ambitious plan to-date

Xcel Energy (XEL) announced its goal to deliver 100% carbon-free electricity to its customers in the eight states that it serves by 2050. The company is looking to lower carbon emissions by 80% from its 2005 levels by 2030. These are the most ambitious plans rolled out thus far in the electric power industry.

Xcel had previously set a goal to reduce carbon emissions by 60% by 2030 and as part of the efforts to reach this target, the company managed to reduce emissions by 35% since 2005. Xcel believes the goal set for 2030 is achievable with the current renewable energy resources and technologies but as far as the 100% goal is concerned, more work is required.

The technologies needed to produce carbon-free electricity are not currently available. Xcel’s long-term plans include the development of these advanced technologies in a cost-effective manner. These plans could include carbon capture technology as well as nuclear power. The company, in cooperation with the government, will try to research and develop various options to reach its goals.

Is the solar sector a good long-term investment?

For its most recent quarter, Xcel saw a slight increase in total operating revenues while earnings saw a slight decline. The company narrowed its EPS guidance range for 2018 to $2.45 to $2.49 from the prior range of $2.41 to $2.51.

Last month, Xcel announced that it was acquiring the Mankato Energy Center from Southern Power, a subsidiary of Southern Company (SO). This acquisition is expected to help Xcel in its efforts to transition to cleaner energy sources and reduce its dependence on coal.

Xcel’s shares have gained over 9.8% so far this year and looking at the past three months, the stock has climbed 8.9%.

 

We’re on Apple News! Follow us to receive the latest stock market, earnings and financial news at your fingertips.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top